Log | Progress In Mind

Log Type	Authored on	Log Message	Log Node	Authored by
OWA Status	Wed, 10/12/2022 - 07:28	israel@progress.im manually updating trust level from 1 to 5		Анонимен
Newsletter opened	Wed, 10/12/2022 - 07:28	Opened	Dr. Mattingly discute abordagens durante a pandemia	Анонимен
Newsletter opened	Wed, 10/12/2022 - 07:28	Opened	Estratégias na esquizofrenia - Aderente à adesão	Анонимен
Newsletter opened	Wed, 10/12/2022 - 07:28	Opened	Dr. Mattingly discute abordagens durante a pandemia	Анонимен
Newsletter opened	Wed, 10/12/2022 - 07:28	Opened	Dra. Deborah Dunsire (CEO Lundbeck) envia mensagem aos profissionais saúde durante a crise do COVID-19	Анонимен
Newsletter opened	Wed, 10/12/2022 - 07:28	Opened	Dr. Mattingly discute abordagens durante a pandemia	Анонимен
Newsletter opened	Wed, 10/12/2022 - 07:28	Opened	Dr. Mattingly discute abordagens durante a pandemia	Анонимен
Newsletter opened	Wed, 10/12/2022 - 07:28	Opened	Dr. Mattingly discute abordagens durante a pandemia	Анонимен
Newsletter opened	Wed, 10/12/2022 - 07:28	Opened	Dr. Mattingly discute abordagens durante a pandemia	Анонимен
Newsletter opened	Wed, 10/12/2022 - 07:28	Opened	Dr. Mattingly discute abordagens durante a pandemia	Анонимен
Newsletter opened	Wed, 10/12/2022 - 07:28	Opened	Dr. Mattingly discute abordagens durante a pandemia	Анонимен
Newsletter opened	Wed, 10/12/2022 - 07:28	Opened	Dr. Mattingly discute abordagens durante a pandemia	Анонимен
Newsletter opened	Wed, 10/12/2022 - 07:28	Opened	Dr. Mattingly discute abordagens durante a pandemia	Анонимен
Newsletter opened	Wed, 10/12/2022 - 07:28	Opened	Dr. Mattingly discute abordagens durante a pandemia	Анонимен
Newsletter opened	Wed, 10/12/2022 - 07:28	Opened	Dr. Mattingly discute abordagens durante a pandemia	Анонимен
Newsletter opened	Wed, 10/12/2022 - 07:28	Opened	Dr. Mattingly discute abordagens durante a pandemia	Анонимен
Newsletter opened	Wed, 10/12/2022 - 07:28	Opened	Dr. Mattingly discute abordagens durante a pandemia	Анонимен
Newsletter opened	Wed, 10/12/2022 - 07:28	Opened	Dr. Mattingly discute abordagens durante a pandemia	Анонимен
OWA Status	Wed, 10/12/2022 - 07:28	Updating trust level from 1 to 2		Анонимен
Newsletter opened	Wed, 10/12/2022 - 07:28	Opened	Dr. Mattingly discute abordagens durante a pandemia	Анонимен
Newsletter opened	Wed, 10/12/2022 - 07:28	Opened	Dr. Mattingly discute abordagens durante a pandemia	Анонимен
Newsletter opened	Wed, 10/12/2022 - 07:28	Opened	Dr. Mattingly discute abordagens durante a pandemia	Анонимен
Newsletter opened	Wed, 10/12/2022 - 07:28	Opened	Dr. Mattingly discute abordagens durante a pandemia	Анонимен
Newsletter opened	Wed, 10/12/2022 - 07:28	Opened	Dr. Mattingly discute abordagens durante a pandemia	Анонимен
Newsletter opened	Wed, 10/12/2022 - 07:28	Opened	Dr. Mattingly discute abordagens durante a pandemia	Анонимен

Log Type	Authored on	Log Message	Log Node	Authored by
OWA Status	Wed, 10/12/2022 - 07:28	israel@progress.im manually updating trust level from 1 to 5		Анонимен
Newsletter opened	Wed, 10/12/2022 - 07:28	Opened	Dr. Mattingly discute abordagens durante a pandemia	Анонимен
Newsletter opened	Wed, 10/12/2022 - 07:28	Opened	Estratégias na esquizofrenia - Aderente à adesão	Анонимен
Newsletter opened	Wed, 10/12/2022 - 07:28	Opened	Dr. Mattingly discute abordagens durante a pandemia	Анонимен
Newsletter opened	Wed, 10/12/2022 - 07:28	Opened	Dra. Deborah Dunsire (CEO Lundbeck) envia mensagem aos profissionais saúde durante a crise do COVID-19	Анонимен
Newsletter opened	Wed, 10/12/2022 - 07:28	Opened	Dr. Mattingly discute abordagens durante a pandemia	Анонимен
Newsletter opened	Wed, 10/12/2022 - 07:28	Opened	Dr. Mattingly discute abordagens durante a pandemia	Анонимен
Newsletter opened	Wed, 10/12/2022 - 07:28	Opened	Dr. Mattingly discute abordagens durante a pandemia	Анонимен
Newsletter opened	Wed, 10/12/2022 - 07:28	Opened	Dr. Mattingly discute abordagens durante a pandemia	Анонимен
Newsletter opened	Wed, 10/12/2022 - 07:28	Opened	Dr. Mattingly discute abordagens durante a pandemia	Анонимен
Newsletter opened	Wed, 10/12/2022 - 07:28	Opened	Dr. Mattingly discute abordagens durante a pandemia	Анонимен
Newsletter opened	Wed, 10/12/2022 - 07:28	Opened	Dr. Mattingly discute abordagens durante a pandemia	Анонимен
Newsletter opened	Wed, 10/12/2022 - 07:28	Opened	Dr. Mattingly discute abordagens durante a pandemia	Анонимен
Newsletter opened	Wed, 10/12/2022 - 07:28	Opened	Dr. Mattingly discute abordagens durante a pandemia	Анонимен
Newsletter opened	Wed, 10/12/2022 - 07:28	Opened	Dr. Mattingly discute abordagens durante a pandemia	Анонимен
Newsletter opened	Wed, 10/12/2022 - 07:28	Opened	Dr. Mattingly discute abordagens durante a pandemia	Анонимен
Newsletter opened	Wed, 10/12/2022 - 07:28	Opened	Dr. Mattingly discute abordagens durante a pandemia	Анонимен
Newsletter opened	Wed, 10/12/2022 - 07:28	Opened	Dr. Mattingly discute abordagens durante a pandemia	Анонимен
OWA Status	Wed, 10/12/2022 - 07:28	Updating trust level from 1 to 2		Анонимен
Newsletter opened	Wed, 10/12/2022 - 07:28	Opened	Dr. Mattingly discute abordagens durante a pandemia	Анонимен
Newsletter opened	Wed, 10/12/2022 - 07:28	Opened	Dr. Mattingly discute abordagens durante a pandemia	Анонимен
Newsletter opened	Wed, 10/12/2022 - 07:28	Opened	Dr. Mattingly discute abordagens durante a pandemia	Анонимен
Newsletter opened	Wed, 10/12/2022 - 07:28	Opened	Dr. Mattingly discute abordagens durante a pandemia	Анонимен
Newsletter opened	Wed, 10/12/2022 - 07:28	Opened	Dr. Mattingly discute abordagens durante a pandemia	Анонимен
Newsletter opened	Wed, 10/12/2022 - 07:28	Opened	Dr. Mattingly discute abordagens durante a pandemia	Анонимен

Patrocinado por

Progress in Mind Brazil

INSCRIÇÃO NEWSLETTER